Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.110
-0.120 (-2.84%)
At close: Nov 9, 2026, 4:00 PM EST
4.080
-0.030 (-0.73%)
After-hours: Nov 9, 2026, 4:39 PM EST
Outset Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 121.97 | 119.48 | 113.69 | 130.38 | 115.38 | 102.6 | |
Revenue Growth | 1.58% | 5.09% | -12.80% | 13.00% | 12.45% | 105.47% |
Cost of Revenue | 70.69 | 72.72 | 74.55 | 101.25 | 97.54 | 94.99 |
Gross Profit | 51.28 | 46.75 | 39.14 | 29.13 | 17.83 | 7.61 |
Selling, General & Admin | 91.79 | 92.27 | 110.67 | 139.8 | 130 | 101.39 |
Research & Development | 21.99 | 21.2 | 36.29 | 56.57 | 48.86 | 36.74 |
Operating Expenses | 113.78 | 113.47 | 146.96 | 196.37 | 178.85 | 138.13 |
Operating Income | -62.5 | -66.71 | -107.82 | -167.24 | -161.02 | -130.52 |
Interest Expense | -13.76 | -13.95 | -23.87 | -12.68 | -3.57 | -1.72 |
Interest & Investment Income | 7.41 | 7.41 | 9.76 | 10.17 | 3.29 | 0.5 |
Other Non Operating Income (Expenses) | -1.61 | - | - | - | - | - |
EBT Excluding Unusual Items | -70.46 | -73.26 | -121.93 | -169.74 | -161.29 | -131.74 |
Merger & Restructuring Charges | 0.01 | 0.01 | -5.56 | -2.53 | - | - |
Other Unusual Items | - | -7.69 | - | - | -1.37 | - |
Pretax Income | -70.45 | -80.94 | -127.49 | -172.27 | -162.66 | -131.74 |
Income Tax Expense | 0.69 | 0.72 | 0.49 | 0.52 | 0.3 | 0.2 |
Earnings From Continuing Operations | - | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 |
Net Income | -71.14 | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 |
Net Income to Common | -71.14 | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 18 | 15 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 18 | 15 | 3 | 3 | 3 | 3 |
Shares Change | 60.35% | 339.24% | 4.78% | 2.94% | 5.64% | 178.69% |
EPS (Basic) | -3.85 | -5.37 | -36.96 | -52.28 | -50.75 | -43.41 |
EPS (Diluted) | -3.85 | -5.37 | -36.96 | -52.28 | -50.75 | -43.41 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -43.18 | -47.13 | -117.22 | -134.81 | -154.05 | -133.37 |
Free Cash Flow Per Share | -2.33 | -3.10 | -33.85 | -40.79 | -47.98 | -43.88 |
Gross Margin | 42.04% | 39.13% | 34.43% | 22.34% | 15.46% | 7.41% |
Operating Margin | -51.24% | -55.84% | -94.84% | -128.27% | -139.56% | -127.21% |
Profit Margin | -58.33% | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% |
Free Cash Flow Margin | -35.40% | -39.44% | -103.10% | -103.40% | -133.53% | -129.99% |
EBITDA | -59.74 | -62.37 | -102.09 | -161.43 | -155.85 | -125.36 |
EBITDA Margin | -48.98% | -52.20% | -89.80% | -123.82% | -135.08% | -122.18% |
D&A For EBITDA | 2.76 | 4.34 | 5.73 | 5.81 | 5.17 | 5.16 |
EBIT | -62.5 | -66.71 | -107.82 | -167.24 | -161.02 | -130.52 |
EBIT Margin | -51.24% | -55.84% | -94.84% | -128.27% | -139.56% | -127.21% |
Revenue as Reported | 121.97 | 119.48 | 113.69 | 130.38 | 115.38 | 102.6 |